Komori
Changes in Officers7096StemCell InstituteInformation and Communications, Services and Others

Notice Concerning the Nomination of Candidates for Directors and Substitute Audit & Supervisory Board Members

In preparation for the Annual General Meeting of Shareholders scheduled for 24 June 2026, 4 director candidates will be nominated. The terms of office of 3 of the 4 incumbent directors will expire, while 茅野 Kei (茅野 圭) will be newly nominated as a director candidate. The election of 1 alternate Audit & Supervisory Board Member will also be submitted to the meeting.

Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Who is moving to which position

Resolved 20 May 2026

Incoming appointee

1 item
Scheduled Appointment DateAt the conclusion of the 27th Annual General Meeting of Shareholders scheduled for 24 June 2026 (subject to approval of the director election proposal at the meeting)
Chino Kei (茅野 圭)
Previous positionExecutive Officer, CFO, Head of Finance and Accounting Headquarters, Administration Division
New positionDirector, Executive Officer, CFO, Head of Finance and Accounting Headquarters, Administration Division
生年月日 23 August 1977入社年 2025
Date of departureAt the conclusion of the 27th Annual General Meeting of Shareholders (expiration of the terms of office of all 4 incumbent directors)
Reason for departure

Expiration of term

Directors after the change4Number
Shareholders’ meeting approvalRequired. Proposals for the election of 4 directors and 1 alternate Audit & Supervisory Board Member will be submitted to the 27th Annual General Meeting of Shareholders scheduled for 24 June 2026.
Reason for change

The Company regards governance as a key management issue, places importance on high-quality discussions and prompt decision-making by the Board of Directors, and will work to strengthen its management control framework and promote workforce diversity.

Who is moving to which position
ItemDetails
Resolution date20 May 2026
Scheduled Appointment DateAt the conclusion of the 27th Annual General Meeting of Shareholders scheduled for 24 June 2026 (subject to approval of the director election proposal at the meeting)
Date of departureAt the conclusion of the 27th Annual General Meeting of Shareholders (expiration of the terms of office of all 4 incumbent directors)
Name of appointeeChino Kei (茅野 圭)
Appointee's new positionDirector, Executive Officer, CFO, Head of Finance and Accounting Headquarters, Administration Division
Appointee's previous positionExecutive Officer, CFO, Head of Finance and Accounting Headquarters, Administration Division
Appointee's date of birth23 August 1977
Year the appointee joined the Company2025
Reason for departureExpiration of term
Reason for changeThe Company regards governance as a key management issue, places importance on high-quality discussions and prompt decision-making by the Board of Directors, and will work to strengthen its management control framework and promote workforce diversity.
Number of directors after the change4 directors (including 2 outside directors)
Subject to Approval by the General Meeting of ShareholdersRequired. Proposals for the election of 4 directors and 1 alternate Audit & Supervisory Board Member will be submitted to the 27th Annual General Meeting of Shareholders scheduled for 24 June 2026.
Items this document does not state (9)
Number of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerWhether the incumbent will remain in officeReasons for appointmentFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company regards governance as a key management issue and will work to promote high-quality discussions and prompt decision-making by the Board of Directors, strengthen its management control framework, and promote workforce diversity.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Nomination of Candidates for Directors and Substitute Audit & Supervisory Board Members | StemCell Institute (7096) timely disclosure | Komori